Temporal Association Between PLA2R Antibodies and Clinical Outcomes in Primary Membranous Nephropathy

In patients with aPLA2R-associated PMN, reduction in circulating aPLA2R precedes clinical remission. Persistence of aPLA2R at the end of therapy is associated with clinical resistance.